Skip to main content

Table 6 Locoregional recurrence within HR-/HER2- subtype by lymph node status (Number = 94).

From: Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

Variable

Locoregional recurrence

No recurrence

LRR probability at 60 month

P-value

Node positive

5

14

23.4%

 

Node negative

5

70

7.8%

0.01

  1. HER2, HER2, human epidermal growth receptor 2; HR, hormone receptor; LRR, locoregional recurrence.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us